The latter hypothesis would be supported by prior studies showing that when calcium channel blockers such as amlodipine are combined with ACE inhibitors or ARBs, there is a reduced risk of peripheral edema and potentially lower cardiovascular risk [20]. This evidence concerns the gene ACE and Peripheral edema.